Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990.

Baudouin Standaert

doi:10.3390/vaccines11111646

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990.

Baudouin Standaert

Open Access

https://doi.org/10.3390/vaccines11111646

Copy DOI

Journal: Vaccines	Publication Date: Oct 27, 2023
Citations: 1	License type: CC BY 4.0

Affiliation: Hasselt University

#Respiratory Syncytial Virus #Oldest Age Groups + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Presently, there are at least five important vaccine producers that have already launched or intend to launch a new vaccine designed to prevent infections caused by the Respiratory Syncytial Virus (RSV), which is highly prevalent in the youngest as well as the oldest age groups [...].

Full Text